TherapeuticsMD (TXMD) Shares Outstanding (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Shares Outstanding (Entity) came in at $136000.0 in Q1 2026, down 98.82% YoY from $11.6 million in Q1 2025, and down 98.82% on a QoQ basis from $11.6 million in Q4 2025.
TherapeuticsMD (TXMD) Shares Outstanding (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Shares Outstanding (Entity) data on file, last reported at $136000.0 in Q1 2026.
- Quarterly Shares Outstanding (Entity) fell 98.82% year-over-year to $136000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $136000.0 (down 98.82% YoY) and the FY2025 annual result came in at $11.6 million, up 100264.2% from the prior year.
- Shares Outstanding (Entity) slipped to $136000.0 in Q1 2026, from $11.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $11.6 million in Q1 2025 to a low of $11532.0 in Q4 2024.
- A 5-year average of $9.3 million and a median of $10.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) slumped 99.89% — and 2025, when it surged 100264.2%.
- Tracing TXMD's Shares Outstanding (Entity) over 5 years: stood at $9.0 million in 2022, then advanced by 15.65% to $10.4 million in 2023, then tumbled by 99.89% to $11532.0 in 2024, then surged by 100264.2% to $11.6 million in 2025, then sank by 98.82% to $136000.0 in 2026.
- The last three Shares Outstanding (Entity) figures came in at $136000.0 (Q1 2026), $11.6 million (Q4 2025), and $11.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 11.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.57 Mn |
| Mar 31, 2026 | 136,000.00 |
| Dec 31, 2025 | 11.57 Mn |
| Sep 30, 2025 | 11.57 Mn |
| Jun 30, 2025 | 11.57 Mn |
| Mar 31, 2025 | 11.55 Mn |
| Dec 31, 2024 | 11,532.00 |
| Sep 30, 2024 | 11.53 Mn |
| Jun 30, 2024 | 11.53 Mn |
| Mar 31, 2024 | 11.53 Mn |
| Dec 31, 2023 | 10.44 Mn |
| Sep 30, 2023 | 10.70 Mn |
| Jun 30, 2023 | 10.22 Mn |
| Mar 31, 2023 | 9.75 Mn |
| Dec 31, 2022 | 9.03 Mn |
| Sep 30, 2022 | 9.26 Mn |
| Jun 30, 2022 | 8.75 Mn |
| Mar 31, 2022 | 8.61 Mn |
| Dec 31, 2021 | 7.96 Mn |
| Sep 30, 2021 | 8.44 Mn |